4//SEC Filing
VANLANDINGHAM JACOB PH.D 4
Accession 0001683168-22-006969
CIK 0001626644other
Filed
Oct 18, 8:00 PM ET
Accepted
Oct 19, 9:27 PM ET
Size
5.6 KB
Accession
0001683168-22-006969
Insider Transaction Report
Form 4
VANLANDINGHAM JACOB PH.D
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-10-14$0.32/sh+1,000,000$318,000→ 2,100,000 totalExercise: $0.32Exp: 2032-10-13→ Common Stock (1,000,000 underlying)
Footnotes (1)
- [F1]Vesting Schedule 250,000 upon signing; 250,000 upon an IND being approved by the FDA for Phase 2; 250,000 upon a listing on a national exchange (Nasdaq, NYSE); and 250,000 one year from Effective Date.
Documents
Issuer
Odyssey Health, Inc.
CIK 0001626644
Entity typeother
Related Parties
1- filerCIK 0001794273
Filing Metadata
- Form type
- 4
- Filed
- Oct 18, 8:00 PM ET
- Accepted
- Oct 19, 9:27 PM ET
- Size
- 5.6 KB